Concepedia

Gregory Hooper

GH

Statistics

Publications

13

Citations

515

H-Index

13

Active since

1995

Affiliations

Roche (United Kingdom)(Current)

Rhodes University

Roche (Switzerland)

University of Chicago

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Gregory Hooper is an author at Roche (United Kingdom) specializing in medicine, pharmacology, and marine biology.

Top concepts

Publications per year

1995–2020

13

Publications

13

Carmabins A and B, New Lipopeptides from the Caribbean Cyanobacterium <i>Lyngbya majuscula</i>

Gregory Hooper, Jimmy Orjala, Randall C. Schatzman et al. · Journal of Natural Products · 1998 · 83 citations

New alkaloids from a South African latrunculid sponge

Gregory Hooper, Michael T. Davies‐Coleman, Michelle Kelly‐Borges et al. · Tetrahedron Letters · 1996 · 68 citations

, ,

Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation–positive melanoma receiving adjuvant vemurafenib

Paolo A. Ascierto, Karl D. Lewis, Anna Maria Di Giacomo et al. · Annals of Oncology · 2020 · 59 citations

Maintenance erlotinib versus erlotinib at disease progression in patients with advanced non-small-cell lung cancer who have not progressed following platinum-based chemotherapy (IUNO study)

Saulius Cicėnas, Sarayut Lucien Geater, Petar Petrov et al. · Lung Cancer · 2016 · 57 citations · Full text

Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies

Yi‐Long Wu, Victor Lee, Chong Kin Liam et al. · Lung Cancer · 2018 · 46 citations

, , +7

1–5 of 13